Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2017 September;42(3)

CURRENT ISSUEMINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,383


Frequency: Quarterly

ISSN 0391-1977

Online ISSN 1827-1634


eTOC

 

Minerva Endocrinologica 2017 September;42(3)

 ORIGINAL ARTICLE 

Minerva Endocrinologica 2017 September;42(3):195-202

Continuous glucose monitoring and hypoglycemia unawareness in type 1 diabetes: a pilot study

Mohamed ZALZALI *, Valérie HOUDELET-GUERINOT, Eric SOCQUARD, Aurore THIERRY, Brigitte DELEMER, Céline LUKAS-CROISIER


 ORIGINAL ARTICLE 

Minerva Endocrinologica 2017 September;42(3):203-12

Thyroid micro-carcinoma: only a diagnostic epidemic?

Paolo DEL RIO, Chiara, MONTANA MONTANA *, Giulia MINGARDI, Giovanna PIVA, Mario SIANESI, Luigi CORCIONE


 ORIGINAL ARTICLE 

Minerva Endocrinologica 2017 September;42(3):213-22

The impact of combined interpretation of localization studies on image-guided surgical approaches for primary hyperparathyroidism

Fatih TUNCA *, Murat AKICI, Yalın IŞCAN, Ismail CEM SORMAZ, Yasemin GILES SENYUREK, Tarık TERZIOĞLU


 ORIGINAL ARTICLE 

Minerva Endocrinologica 2017 September;42(3):223-7

The value of color Doppler ultrasound in the diagnosis of lower extremity vascular disease in type 2 diabetes and an analysis of related factors

Le JIANG, Yuehua ZHAO *


 REVIEW 

Minerva Endocrinologica 2017 September;42(3):228-37

Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes

Alessandro, MANDURINO-MIRIZZI, Sergio LEONARDI, Chiara MELLONI *


 REVIEW 

Minerva Endocrinologica 2017 September;42(3):238-47

Novel acquisitions in the diagnosis of medullary thyroid carcinoma

Pierpaolo TRIMBOLI *, Anna CRESCENZI, Enrico SAGGIORATO, Giorgio TREGLIA, Luca GIOVANELLA


 REVIEW 

Minerva Endocrinologica 2017 September;42(3):248-70

Fibroblast growth factors: new insights, new targets in the management of diabetes

Ioannis KYROU, Martin O. WEICKERT, Seley GHARANEI, Harpal S. RANDEVA, Bee K., TAN *


 REVIEW 

Minerva Endocrinologica 2017 September;42(3):271-9

The possible impact of advanced glycation end products on pregnancy outcome in women with diabetes mellitus type 1

Magdalena, PERTYNSKA-MARCZEWSKA *, Katarzyna CYPRYK


 REVIEW 

Minerva Endocrinologica 2017 September;42(3):280-9

Emergence of SFRP5 as a pleiotropic adipocytokine and its association with Wnt signaling pathways

Chandrasekaran JAIKANTH, Prema GURUMURTHY *, Thillai INDHUMATHI, Kotturathu M., CHERIAN


 LETTERS TO THE EDITOR 

Minerva Endocrinologica 2017 September;42(3):290-1

The complexity of elucidating whether novel mutations in the hepatocyte nuclear factor one alpha gene are responsible for maturity onset diabetes of the young in ethnic minorities

Pinky KURANI*, Devin STEENKAMP


 LETTERS TO THE EDITOR 

Minerva Endocrinologica 2017 September;42(3):291-4

Difficult management in parathyroid carcinoma with synchronous parathyroid hyperplasia

Fabio PAGNI, Giovanni CASELLA *, Francesca M. BOSISIO, Marilena COSTANTINI, Giannantonio FIORETTA, Guglielmo NICOLETTI, Vittorio BALDINI, Camillo DI BELLA


 LETTERS TO THE EDITOR 

Minerva Endocrinologica 2017 September;42(3):294-6

Cardiovascular disease in PCOS is related to severe insulin resistance, not mild

Michael H., DAHAN *, Fahim ABBASI, Gerald M. REAVEN


top of page